FY2023 EPS Estimates for Edgewise Therapeutics, Inc. Increased by Wedbush (NASDAQ:EWTX)
Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) – Equities researchers at Wedbush lifted their FY2023 earnings per share (EPS) estimates for shares of Edgewise Therapeutics in a report issued on Monday, January 22nd. Wedbush analyst L. Chico now expects that the company will earn ($1.50) per share for the year, up from their prior forecast […]